Jump to content

Survival advantage from imatinib compared with the combination interferon- plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials (Q58179557)

From Wikidata
scientific article published on 20 April 2006
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Survival advantage from imatinib compared with the combination interferon- plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials
    scientific article published on 20 April 2006

      Statements

      Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials (English)

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit